Tower Research Capital LLC (TRC) - BENITEC BIOPHARMA INC ownership

BENITEC BIOPHARMA INC's ticker is BNTC and the CUSIP is 08205P100. A total of 22 filers reported holding BENITEC BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of BENITEC BIOPHARMA INC
ValueSharesWeighting
Q2 2023$1,784
+89100.0%
7,465
-1.3%
0.00%
Q1 2023$2
+100.0%
7,5610.0%0.00%
Q4 2022$1
-100.0%
7,561
-2.5%
0.00%
Q3 2022$3,000
-25.0%
7,755
+101.5%
0.00%
Q2 2022$4,0000.0%3,848
+141.4%
0.00%
Q1 2022$4,000
+300.0%
1,594
+1135.7%
0.00%
Q1 2021$1,0001290.00%
Other shareholders
BENITEC BIOPHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
SILVERARC CAPITAL MANAGEMENT, LLC 498,009$1,778,0001.00%
SUVRETTA CAPITAL MANAGEMENT, LLC 769,000$2,745,0000.05%
WealthTrust Axiom LLC 12,950$46,0000.02%
Private Wealth Advisors, LLC 15,043$49,0000.01%
Virtu Financial LLC 22,924$82,0000.01%
UBS Group AG 1,061$4,0000.00%
BANK OF AMERICA CORP /DE/ 91$00.00%
WELLS FARGO & COMPANY/MN 41$00.00%
NORTHERN TRUST CORP 11,813$42,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of BENITEC BIOPHARMA INC shareholders